| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
David K Morris is See Remarks at GRDN. David K Morris's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $36.6M at current prices.
Our model assigns David K Morris a below-average insider score of 14/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -78.7%.
The GRDN filings lean toward selling, a net 625,614 shares.
David K Morris has 10 Form 4 filings on record from September 2024 to September 2026, all as Guardian Pharmacy Services (GRDN), 2024–2026.
The 11 reported transactions were 4 option exercises, 3 open-market sales, 2 stock awards and 2 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $14.4M.
The largest open-market sale was 437,759 shares of GRDN at an average $20.16 on May 28, 2025, about $8.8M. Twelve months later GRDN was up 81%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.